Bristol-Myers Squibb buy Truist Financial Co.
Start price
06.10.23
/
50%
€53.50
Target price
06.10.24
€79.27
Performance (%)
-21.54%
Price
03.05.24
€40.88
Summary
This prediction is currently active. The prediction for Bristol-Myers Squibb disappoints with a performance of -21.54%. A total of €1.10 was paid as dividends for this prediction. This prediction currently runs until 06.10.24. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Bristol-Myers Squibb | -2.493% | -2.493% |
iShares Core DAX® | -0.922% | -1.993% |
iShares Nasdaq 100 | 0.371% | -0.868% |
iShares Nikkei 225® | 2.224% | -5.187% |
iShares S&P 500 | -0.026% | -0.918% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $84.00 price target on the stock.
Ratings data for BMY provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€55.60
15.09.23
15.09.23
€78.67
15.09.24
15.09.24
-23.53%
03.05.24
03.05.24